Deakin University
Browse

File(s) not publicly available

RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

journal contribution
posted on 2018-11-05, 00:00 authored by Mustafa Khasraw, Kerrie McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, Elizabeth Barnes, Mark Rosenthal, Craig Gedye, Elizabeth Hovey, Benjamin Ellingson, John Simes, Annette Tognela, Eng-Siew Koh, Hui Gan, Michael Back, Zarnie Lwin
RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

History

Journal

Neuro-Oncology

Volume

20

Pagination

vi235-vi235

Location

Oxford, Eng.

Publisher DOI

ISSN

1522-8517

eISSN

1523-5866

Language

eng

Publication classification

E3 Extract of paper

Issue

suppl_6

Publisher

Oxford University Press

Usage metrics

    Research Publications

    Categories

    Keywords

    GBMcancerpost radiationNivolUmabTMZnewly diagnosed3209 Neurosciences3211 Oncology and carcinogenesis

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC